article thumbnail

Renova Therapeutics Raises $7.52M

socalTECH

The company said the funding primarily came from high net worth individuals. Bradbury has joined the company''s board. Bradbury is a member of life sciences consulting and investment firm BioBrit LLC; he also served as President and CEO of Amylin Pharmaceuticals. As part of the funding, Daniel M.

Bradbury 138